--- title: "ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10%" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/263499854.md" description: "ZHONGSHENGYAOYE announced that the revenue for the third quarter was 589 million yuan, an increase of 8.35% year-on-year; the net profit was 62.6822 million yuan, an increase of 2.10% year-on-year. The revenue for the first three quarters was 1.889 billion yuan, a decrease of 1.01% year-on-year; the net profit was 251 million yuan, an increase of 68.40% year-on-year" datetime: "2025-10-30T11:08:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/263499854.md) - [en](https://longbridge.com/en/news/263499854.md) - [zh-HK](https://longbridge.com/zh-HK/news/263499854.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263499854.md) | [English](https://longbridge.com/en/news/263499854.md) # ZHONGSHENGYAOYE: Net profit in the third quarter was 62.6822 million yuan, a year-on-year increase of 2.10% ZHONGSHENGYAOYE announced that the revenue for the third quarter was 589 million yuan, an increase of 8.35% year-on-year; the net profit was 62.6822 million yuan, an increase of 2.10% year-on-year. The revenue for the first three quarters was 1.889 billion yuan, a decrease of 1.01% year-on-year; the net profit was 251 million yuan, an increase of 68.40% year-on-year ### 相關股票 - [ZHONGSHENGYAOYE (002317.CN)](https://longbridge.com/zh-HK/quote/002317.CN.md) ## 相關資訊與研究 - [Peptides in the pipeline: How companies are overcoming the early-stage challenges](https://longbridge.com/zh-HK/news/278589651.md) - [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/zh-HK/news/278461777.md) - [Bilibili posts first full year of GAAP profit as ad business strengthens](https://longbridge.com/zh-HK/news/278062990.md) - [Tennis-Monfils bids emotional farewell to Indian Wells](https://longbridge.com/zh-HK/news/278193321.md) - [12:53 ETThe Meadows Celebrates 50 Years of Trauma-Focused Care and Clinical Leadership](https://longbridge.com/zh-HK/news/278591807.md)